Rhenium-SCT® now offered in Bologna

September 13, 2017

OncoBeta® GmbH is privileged to announce the start of the next Rhenium-SCT® treatment center located in Bologna Italy. Prof. Stefano Fanti, Director of the Nuclear Medicine and his team are working close together with Prof. Annalisa Patrizi, Director of Dermatology and her team at the Policlinico S.Orsola in Bologna to…

Read more

OncoBeta Appoints New Managing Director

July 25, 2017

OncoBeta GmbH has announced today that its board of directors has unanimously chosen Shannon D. Brown III as the organization’s new Managing Director. Brown, who currently serves as OncoBeta International’s vice president of global business development, will take over duties as of 01 Sep. 2017   “The board is extremely…

Read more

Rhenium-SCT® Receives Positive Assessment from German Society of Nuclear Medicine

July 13, 2017

Rhenium-SCT® Receives Positive Assessment the from German Society of Nuclear Medicine (DGN e.V.) pertaining to their treatment of Non-Melanoma Skin Cancers with the Rhenium-SCT® Therapy. The radiation committee came to a unanimous conclusion that Re-188-SCT can be considered an accepted medicine [Heilkunde] in accordance with the German Radiation Protection Ordinance….

Read more

OncoBeta Speaks at the World Rhenium Congress

June 1, 2017

OncoBeta® GmbH is pleased to announce the acceptance of the invitation to speak at the World Rhenium Congress hosted by the Dept. of Nuclear Medicine, KMCH in Coimbatore, India. Dr. Thomas Wendler, one of the managing directors at OncoBeta will speak about their new therapy for Non-Melanoma Skin Cancer Rhenium-SCT®….

Read more

OncoBeta Receives Eurostars Grant

February 1, 2017

We are happy to announce that OncoBeta® GmbH Germany, Leiden University Medical Center Netherlands and Metaoptima Technology Inc. Canada have received the eurostars SkinHeal Grant. The three-year grant of 2,515,230.00 Euros for Medical device technology (instrumentation, medical imaging, radiology) development. The long-term goal is to heal the most common skin…

Read more

OncoBeta receives Baymed Grant for Medical Technology

January 1, 2017

Baymed 2017, Garching, Germany. OncoBeta® GmbH is proud to announce recipience of the Bavarian research program “Medical Technology”, from the Bavarian Ministry of Economic Affairs and Media, Energy and Technology supports joint and cooperation projects for research and development work in the field of medical technology. Support is given to…

Read more